At EvoTissue, we collaborate with multiple FDA-registered graft manufacturers and vendors to provide a comprehensive range of advanced wound care products, including placental tissue allografts, skin substitutes, and cellular or acellular matrices. Our commitment is to ensure timely access to high-quality grafts that meet the diverse clinical needs of patients.
We do not endorse or promote any single manufacturer or vendor over another. Product availability and recommendations are based on:
✅ Clinical need
✅ Provider discretion
✅ Wound characteristics
✅ Payer coverage criteria
✅ Supply logistics
While EvoTissue may maintain logistical or distribution relationships with certain manufacturers or vendors, clinical decision-making and product selection remain the sole responsibility of the licensed healthcare providers treating the patient.
Regulatory Compliance
EvoTissue complies with all applicable federal and state laws, including:
✅ The Centers for Medicare & Medicaid Services (CMS) guidelines
✅ The Anti-Kickback Statute
✅ The Physician Payments Sunshine Act (Sunshine Act)
These regulations ensure transparency, ethical business practices, and the prioritization of patient care.
Patient Care Commitment
All treatment decisions are made independently by licensed healthcare providers, with patient safety and clinical efficacy as our highest priorities.